Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

326
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
326
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.3K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.3K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.5K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.

The Journal of biological chemistry·2020
Same author

Efficient solar hydrogen production coupled with organics degradation by a hybrid tandem photocatalytic fuel cell using a silicon-doped TiO<sub>2</sub> nanorod array with enhanced electronic properties.

Journal of hazardous materials·2020
Same author

Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.

Scientific reports·2020
Same author

RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.

Evidence-based complementary and alternative medicine : eCAM·2020
Same author

Observation of changes in the number of myocardial capillaries in rabbits after treatment of acute myocardial infarction by Tongxinluo superfine powder.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2020
Same author

Circulating Factors in Trauma Plasma Activate Specific Human Immune Cell Subsets.

Injury·2020
Same journal

SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.

Briefings in bioinformatics·2026
Same journal

Genome assemblies and annotations are not static and need support for tracking their evolution.

Briefings in bioinformatics·2026
Same journal

A historical journey of metabolite-protein interaction discovery: from data harmonization to AI-driven prediction.

Briefings in bioinformatics·2026
Same journal

Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction.

Briefings in bioinformatics·2026
Same journal

Prediction of drug hypersensitivity by comprehensive modeling of HLA-peptidomes.

Briefings in bioinformatics·2026
Same journal

EssTFNet: integration of adaptive time-frequency and DNA language models for interpretable human essential gene prediction.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K

Identification of drug-target interactions via multiple kernel-based triple collaborative matrix factorization.

Yijie Ding1, Jijun Tang2, Fei Guo3

  • 1Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, P.R.China.

Briefings in Bioinformatics
|February 8, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a novel machine learning method, multiple kernel-based triple collaborative matrix factorization (MK-TCMF), for predicting drug-target interactions (DTIs). The MK-TCMF method effectively integrates diverse data types to improve cancer drug discovery.

Keywords:
bipartite networkdrug–target interactions networkmatrix factorizationmulti-information fusionmultiple kernel learning

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Machine learning in drug discovery

Background:

  • Drug-target interactions (DTIs) are crucial for targeted cancer therapies, but experimental detection is time-consuming.
  • Machine learning (ML) accelerates drug screening, yet few methods effectively fuse multiple data sources for DTI prediction.
  • Existing computational methods for DTI prediction often lack comprehensive data integration strategies.

Purpose of the Study:

  • To develop an advanced computational method for predicting drug-target interactions (DTIs) by integrating multiple biological and chemical data sources.
  • To propose a novel multiple kernel-based triple collaborative matrix factorization (MK-TCMF) model for enhanced DTI prediction.
  • To improve the efficiency and accuracy of identifying potential drug candidates for cancer treatment.

Main Methods:

  • Developed a multiple kernel-based triple collaborative matrix factorization (MK-TCMF) model.
  • Integrated diverse data sources including chemical, biological, and clinical information using a multi-kernel learning (MKL) algorithm.
  • Employed matrix decomposition to derive latent feature matrices for drug and target spaces, and a bi-projection matrix.

Main Results:

  • The MK-TCMF model demonstrated superior performance in predicting DTIs compared to existing computational methods across four independent test datasets.
  • The multi-kernel learning algorithm effectively regulated kernel weights, assigning the highest importance to drug side-effects and target sequence information.
  • The proposed method successfully integrated multiple data modalities, leading to more accurate DTI predictions.

Conclusions:

  • The MK-TCMF method offers a powerful and accurate approach for predicting drug-target interactions, significantly aiding in the identification of novel therapeutic agents.
  • Effective fusion of multiple data types, particularly drug side-effects and target sequences, is critical for improving DTI prediction accuracy.
  • This computational strategy can accelerate the drug discovery pipeline for targeted cancer therapies, reducing reliance on laborious experimental methods.